The presence of splice variant of TFF2 in CCA patients suggested that alternative splicing may be a process which regulates the expression of TFF2. Therefore, it is conceivable that the overexpression of splice variant may play a pivotal role as a dominant inhibitor of wild-type function. This evidence concerns the gene TFF2 and cholangiocarcinoma.